SCHEMBL5076265

SCHEMBL5076265

Cc1c(CN(C)C(=O)C=Cc2cnc3c(c2)CN(CCCN2CCOCC2)CC(=O)N3)sc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5076258 1.00
Hydrochloric Acid SCHEMBL1253082 0.99
Hydrochloric Acid SCHEMBL1253077 0.99
SCHEMBL5079721 0.98
SCHEMBL5079722 0.98
Hydrochloric Acid SCHEMBL1254051 0.97
Hydrochloric Acid SCHEMBL1254049 0.97
SCHEMBL5082760 0.94
SCHEMBL5082755 0.94
Hydrochloric Acid SCHEMBL1252983 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-B1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY DEBIOPHARM INT SA (CH) 2014-06-25 EP claimed
EP-1608377-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARM INC (CA) 2008-10-01 EP claimed